NASHVILLE, Tenn., Jan. 13 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. is pleased to announce the appointment of Barry Lee as Product Director. In this role, Mr. Lee will draw upon his 24 years of pharmaceutical sales and marketing experience to lead the prospective launch and commercialization of new products for the company.
"We are extremely pleased to welcome Mr. Lee to Cumberland's management team," said A.J. Kazimi, CEO of Cumberland Pharmaceuticals. "As we work to continue to grow the company, we believe Barry's extensive experience and solid track record of success will be extremely valuable in helping Cumberland deliver promising new products to patients who can benefit."
Mr. Lee joins Cumberland from Bayer Healthcare Pharmaceuticals where he
held a variety of sales and marketing positions during his 24-year tenure. In
addition to leading sales training and development efforts, he oversaw the
launch of the company's Yasmin(R) product, which was one of the most
successful industry launches of its time, reaching $92 million in net sales
its first year on the market. Under his leadership, the product grew to $320
million in net sales over a four-year period. Mr. Lee is a graduate of
Cumberland Pharmaceuticals Inc. is a Tennessee-based specialty pharmaceutical company that develops and markets branded, prescription products for targeted physician segments, including hospital acute care and gastroenterology. Cumberland is dedicated to providing innovative products that improve quality of care for patients. For more information, please visit the Cumberland Pharmaceuticals web site at www.cumberlandpharma.com.
|SOURCE Cumberland Pharmaceuticals Inc.|
Copyright©2009 PR Newswire.
All rights reserved